10x Genomics, Inc. (TXG) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $10.51B, a trailing price-to-earnings ratio of 538.0 and a free-cash-flow yield of 1.3%. Over the most recent reported fiscal year, revenue grew 5.2%.